Detection and significance of antithrombin Ⅲ in patients with deep venous thrombosis of lower extremities

doi:10.3877/cma.j.issn.2095-5782.2020.03.008

Abstract

Abstract:

Objective

To investigate the difference of the plasma antithrombin Ⅲ (ATⅢ) between deep venous thrombosis and non-thrombosis patients.

Methods

A retrospective analysis was performed on the clinical data of 252 patients with deep vein thrombosis of lower extremities and 212 patients without thrombotic diseases in our hospital from January 2017 to December 2018. The ATⅢ level in all patients was measured,and the difference of ATⅢ level was compared between the two groups.

Results

There is no significant difference in ATⅢ level (IU/dL) between the deep venous thrombosis group (85.16±15.58) and the non-thrombosis group (87.92±19.09).

Conclusions

In this study, there was no difference in ATⅢlevel between deep venous thrombosis group and non-thrombosis group. The measurement of ATⅢ level in patients with deep vein thrombosis can provide a reference for anticoagulant therapy.

Key words: Deep venous thrombosis, Antithrombin Ⅲ, Anticoagulant

Jie Kong, Boxiang Zhao, Maofeng Gong, Zhaoxuan Lu, Yangyi Zhou, Liang Chen, Haobo Su, Wensheng Lou, Guoping Chen, Jianping Gu, Xu He. Detection and significance of antithrombin Ⅲ in patients with deep venous thrombosis of lower extremities[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2020, 08(03): 233-236.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjrfsxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-5782.2020.03.008

https://zhjrfsxdzzz.cma-cmc.com.cn/EN/Y2020/V08/I03/233

Figures/Tables 5

References 14

[1]	Patterson BO, Hinchliffe R, Loftus IM, et al. Indications for catheter-directed thrombolysis in the management of acute proximal deep venous thrombosis[J]. Arterioscler Thromb Vasc Biol, 2010, 30(4): 669-674.
[2]	Xiao L, Huang DS, Shen J, et al. Introducer curving technique for the prevention of tilting of transfemoral Gunther Tulip inferior vena cava filter[J]. Korean J Radiol, 2012, 13(4):483-491.
[3]	Suehisa E, Nomura T, Kawasaki T, et al. Frequency of natural coagulation inhibitor (antithrombinⅢ, protein C and protein S) deficiencies in Japanese patients with spontaneous deep vein thrombosis[J]. Blood Coagul Fibrinolysis, 2001, 12(2): 95-99.
[4]	中国医师协会介入医师分会，中华医学会放射学分会介入专业委员会，中国静脉介入联盟．下肢深静脉血栓形成介入治疗规范的专家共识（第2版）[J]．介入放射学杂志，2019, 28(1): 1-10.
[5]	Maclean PS, Tait RC. Hereditary and acquired antithrombin deficiency: Epidemiology, pathogenesis and treatment options[J]. Drugs, 2007, 67(10):1429-1440.
[6]	Hunt LT, Dayhoff MO. A surprising new protein superfamily containing ovalbumin, antithrombin-Ⅲ, and alpha 1-proteinase inhibitor[J]. Biochem Biophys Res Commun, 1980, 95(2): 864-871.
[7]	Hirsh J, Piovella F, Pini M. Congenital antithrombin Ⅲ deficiency. Incidence and clinical features[J]. Am J Med, 1989, 87(3B): 34S-38S.
[8]	Harper PL, Luddington RJ, Daly M, et al. The incidence of dysfunctional antithrombin variants: Four cases in 210 patients with thromboembolic disease[J]. Br J Haematol, 1991, 77(3): 360-364.
[9]	Mateo J, Oliver A, Borrell M, et al. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism—results of the Spanish Multicentric Study on Thrombophilia (EMET-Study)[J]. Thromb Haemost, 1997, 77(3): 444-451.
[10]	Sanson BJ, Simioni P, Tormene D, et al. The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: A prospective cohort study[J]. Blood, 1999, 94(11): 3702-3706.
[11]	Kottke-Marchant K, Duncan A. Antithrombin deficiency: Issues in laboratory diagnosis[J]. Arch Pathol Lab Med, 2002, 126(11): 1326-1336.
[12]	Franchini M, Veneri D, Salvagno GL, et al. Inherited thrombophilia[J]. Crit Rev Clin Lab Sci, 2006, 43(3): 249-290.
[13]	李金泉，江一民，吴翼伟，等．抗凝血酶Ⅲ测定在血栓形成性疾病中的诊断价值[J]．苏州医学院学报，2000, 20(6): 541-542.
[14]	Nomura F, Ihara A, Yoshitatsu M, et al. Relationship between coagulation cascade, cytokine, adhesion molecule and aortic aneurysm[J]. Eur J Cardiothorac Surg, 2003, 23(6): 1034-1038; discussion 1038-1039.

[1]	Zhiman Xiao, Yu Gong, Jingling Xie, Binwei Liu. Comparative study on occurrence of lower limb deep vein thrombosis after upper and lower limbs arthroscopic surgeries [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(05): 601-606.
[2]	Cheng Zhang, Haijun He, Guangyi Zhang, Binglang Xiong, Tianzhao Tian, Shiyi Sun, Zixuan Wu. Meta-analysis anticoagulant prevention of thrombosis after knee arthroscopy [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(03): 340-347.
[3]	Xiaofang Zhang, Ying Zhang, Xianjin Liu, Hong Xue. Comparision of three common index systems in evaluating short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure [J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2022, 15(05): 353-359.
[4]	Ouchan Hu, Zhongying Huang. Current status and outlook of research in treatment of unexplained recurrent spontaneous abortion [J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(01): 16-22.
[5]	Zaibo Zhang, Bingyu Wang, Zhikai Jiao, Bibo Tan. Risk factors for lower extremity deep venous thrombosis after gastric cancer surgery: A Meta-analysis [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 475-480.
[6]	Yunfeng Li, Yongjiang Yu. Research progress in perioperative treatment of elderly inguinal hernia patients treated with anticoagulation [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2023, 17(03): 247-250.
[7]	Cuiping Li, Xiaoyan Chen, Shiyu Qian, Huizhu Lin, Caihui Zeng, Li Yang, Jianxi Lu. Effects of different anticoagulant preservation solutions on the proliferation and killing effects of NK cells cultured in umbilical cord blood [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 572-576.
[8]	Juan Che, Junyang Liu. Related factors of occurrence of deep venous thrombosis in patients with proximal humerus fracture [J]. Chinese Journal of Shoulder and Elbow(Electronic Edition), 2023, 11(02): 146-149.
[9]	Bixuan Song, Haichuan Guo, Ziyu Han, Ruijuan Zhou, Chengsi Li, Chenni Ji. Analysis of risk factors and construction of predictive nomogram for deep vein thrombosis in the lower extremity after open wedge high tibial osteotomy [J]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2023, 09(04): 226-232.
[10]	Xuehui Gao, Xiaojing Zou, Xiaobo Yang, You Shang. Anticoagulation application of Nafamostat Mesylate in critically ill patients received continuous renal replacement therapy and extracorporeal membrane oxygenation [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(02): 210-216.
[11]	Shenghua Liu, Xing Zheng. Anticoagulation management strategies during pregnancy with mechanical prosthetic heart valve [J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2022, 11(01): 23-26.
[12]	Jingping Ge, Yuanyuan Yin, Juan He, Yan Li. Effect of simple intelligent air pressure band blocking time on thrombolysis of lower extremity deep venous thrombosis [J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2022, 10(04): 387-390.
[13]	Bo Peng, Musha Kadeerjiang·, Na Liu, Changhui Yu, Tianqi Yu, Hongyou Fan, Zhi Li. Risk factors and characteristics of venous thromboembolism in Xinjiang Kizilsu Kirgiz Autonomous Prefecture [J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2022, 10(03): 250-253.
[14]	Qiu Li, Weixia Yang, Weiwen Wu. Clinical diagnostic features of Trousseau′s syndrome and literature review [J]. Chinese Journal of Diagnostics(Electronic Edition), 2023, 11(01): 17-20.
[15]	Yiwei Yin, Zheng Jiao, Wentao Fang. Medications management of preoperative basic diseases in thoracic surgery [J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2022, 09(04): 255-263.

Please choose a citation manager

Content to export